Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
NCT00259402
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Esophageal Neoplasms
Interventions
DRUG:
Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)
Sponsor
Sanofi